PET-adaptive beacopp- versus ABVD-based therapies for advanced-stage (AS) classic Hodgkin lymphoma (cHL): Survival comparisons leveraging a multi-state model and analyzing the impact of a-hipi scores…

Overview of attention for article published in Blood, November 2025

Altmetric Badge

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 4,409 followers.

RT @DrAEvens: 👏Congratulations to Dr Zhu (Jenny) Cui, recent Tufts Heme/Onc fellow, now @BrownMedPhys faculty on a great presentation on in…

👏Congratulations to Dr Zhu (Jenny) Cui, recent Tufts Heme/Onc fellow, now @BrownMedPhys faculty on a great presentation on innovative #multistate modeling (SEE: https://t.co/Qx7f74LWmh). ➡️The aims were to: 1) to compare disease outcomes of advanced-sta…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.